Xencor

XNCR

Market cap $843M

11.81 USD

+0.24

2.07%

At close Updated Feb 24, 4:00 PM EST

Pre-market

After hours

11.81

0.00

1 day

2.07%

5 days

3.14%

1 month

-9.29%

3 months

-29.45%

6 months

47.44%

Year to date

-20.84%

1 year

-21.58%

5 years

-75.65%

10 years

5.07%

About: Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Employees: 250

Healthcare Biotechnology